Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Knight's lateral movement and puck-handling skills have especially stood out during his stellar first three Hawks starts.

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...

The Senate Health, Education, Labor, and Pensions Committee cancelled Dr. Weldon’s confirmation hearing, which was scheduled ...

The New Jersey Economic Development Authority board March 12 approved $5.24 million in tax credits under the Emerge Program ...

Sun Pharmaceutical Industries Ltd. closed 14.10% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Vishal Manchanda, Pharma Analyst at Systematix Group, stated that Sun Pharmaceutical stands to gain significantly from its recent acquisition of Checkpoint Therapeutics, as it provides access to the ...

Macquarie segregates stocks in three lists for its bottom-up ideas. These lists are Stars Core 6, Tactical, and Rising Star.

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...

Sun Pharmaceutical Industries Ltd. closed 14.48% below its 52-week high of 1,960.20 rupees, which the company reached on ...